Public Health and Autism Science advancing Equitable Strategies across the life course (PHASES)
Project Number1P50HD111142-01
Former Number1P50MH131008-01
Contact PI/Project LeaderROBINS, DIANA L Other PIs
Awardee OrganizationDREXEL UNIVERSITY
Description
Abstract Text
Autism is a common neurodevelopmental condition that affects functioning and well-being in a myriad of
domains across the life course. The proposed Autism Center of Excellence, “Public Health and Autism Science
advancing Equitable Strategies across the life course” (PHASES) application proposes to employ an
overarching public health research framework to examine health determinants, health inequity – especially in
under-represented diverse populations – and health services delivery and their impact on health outcomes.
Projects in our center highlight different stages of the life course – early childhood, adolescence to young
adulthood, and older adults. Project 1 addresses predictors of age of diagnosis among young children with
autism, with emphasis on inequities in access to universal, high-fidelity screening during primary care visits.
Projects 2 and 3 examine Medicaid claims and other national data to address key issues arising from the
disproportionate burden of co-occurring health conditions in autistic adolescents and young adults (Project 2)
and middle age-to-older adults (Project 3). Project 4 develops a new tool to support transition from pediatric to
adult healthcare in young adults on the spectrum, with emphasis on minimally verbal adults. Each of the four
studies targets unique understudied groups characterized by potentially modifiable adverse outcomes: young
children with delayed autism detection, autistic adolescents and young adults with co-occurring conditions,
older autistic adults with co-occurring health and cognitive deterioration, and young autistic, minimally verbal
adults at risk for poor health care transition. The three Center Aims address the following research goals at
three different key life stages: Aim 1 investigates modifiable health determinants for autistic individuals; Aim 2
evaluates inequities in health and health services, especially in under-represented minorities and economically
disadvantaged persons on the autism spectrum; and Aim 3 examines the relations between health services
delivery and health outcomes. The Center will be supported by three cores facilitating synergy across projects:
the Administrative Core streamlines communication and collaboration across projects; the Dissemination and
Outreach Core facilitates engagement with diverse stakeholders and expands our existing activities to
emphasize bidirectional communication between our team and the community; and the Data Core ensures
quality, integrity, and security of data from large and diverse sources (e.g. Medicaid, Medicare, electronic
health records). Overall, the Center will address preventable adverse outcomes and promote wellbeing in
individuals on the autism spectrum, with a focus on several priorities identified by the Interagency Autism
Coordinating Committee, including research across the lifespan, reducing inequities, and improving health
outcomes for autistic persons.
Public Health Relevance Statement
Autistic persons experience health inequities throughout the life course, which result in preventable adverse
outcomes disproportionally affecting minority and economically disadvantaged autistic individuals. The Public
Health and Autism Science advancing Equitable Strategies across the life course (PHASES) Center uses an
integrated public health research framework to characterize and mitigate health inequities in vulnerable
subgroups on the autism spectrum.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdolescenceAdolescentAdolescent and Young AdultAdultAffectAgeAgingBackBasic ScienceBiological FactorsChildChildhoodClinical SciencesCognitiveCollaborationsCommunicationCommunitiesCommunity NetworksComplexDataData SecurityDetectionDeteriorationDiagnosisDiagnostic ServicesEarly DiagnosisEconomically Deprived PopulationElderlyElectronic Health RecordEnsureEnvironmental Risk FactorFeedsFutureGoalsHealthHealth ServicesHealthcareIndividualInstitutesKnowledgeLifeLife Cycle StagesLinkLongevityMedicaidMedicareMinorityOutcomePeriodicityPersonal SatisfactionPersonsPopulationPopulation HeterogeneityPopulations at RiskPrevalencePreventionPreventivePrimary Health CarePublic HealthQuality of lifeResearchResearch Project GrantsRiskScienceSecurityServicesSourceStrategic PlanningStructureSubgroupSystemTestingToddlerUnderrepresented MinorityUnited States National Institutes of HealthVisitVulnerable Populationsadolescent with autism spectrum disorderadult with autism spectrum disorderadverse outcomeautism spectrum disorderautisticautistic childrendata integrationdiverse dataearly childhoodethnic diversityevidence baseexperiencehealth care deliveryhealth care servicehealth inequalitiesimprovedindividuals with autism spectrum disorderinnovationmiddle ageoutreachpressureprogram disseminationprogramspublic health researchracial and ethnicscreeningservice deliverysocial factorssynergismtoolyoung adult
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
002604817
UEI
XF3XM9642N96
Project Start Date
06-September-2022
Project End Date
31-August-2027
Budget Start Date
06-September-2022
Budget End Date
31-August-2023
Project Funding Information for 2022
Total Funding
$2,119,979
Direct Costs
$1,466,121
Indirect Costs
$653,858
Year
Funding IC
FY Total Cost by IC
2022
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$2,119,979
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1P50HD111142-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P50HD111142-01
Patents
No Patents information available for 1P50HD111142-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P50HD111142-01
Clinical Studies
No Clinical Studies information available for 1P50HD111142-01
News and More
Related News Releases
No news release information available for 1P50HD111142-01
History
No Historical information available for 1P50HD111142-01
Similar Projects
No Similar Projects information available for 1P50HD111142-01